Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
about
Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitorsRecombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitorsRecombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitorsComparison of bypassing agents in bleeding reduction in treatment of bleeding episodes in patients with haemophilia and inhibitorsCovalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.Suppression of FVIII inhibitor formation in hemophilic mice by delivery of transgene modified apoptotic fibroblasts.Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in ItalyCurrent difficulties and recent advances in bypass therapy for the management of hemophilia with inhibitors: a new and practical formulation of recombinant factor VIIa.Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.Literature review of surgery management in inhibitor patients.Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.Health economics of treating haemophilia A with inhibitors.Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors.Management of bleeding emergencies: when to use recombinant activated factor VII.Total joint replacement in patients with inhibitors.The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief reviewOptions for treating acute bleeds in addition to bypassing agents: extracorporeal immunoadsorption, FVIII/FIX, desmopressin and antifibrinolytics.Haemophilia therapies.Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors.Guidelines for the use of recombinant activated factor VII in massive obstetric haemorrhage.New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors.Inhibitors in mild/moderate haemophilia A: two case reports and a literature review.The history and evolution of the clinical effectiveness of haemophilia type a treatment: a systematic review.Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors.Pharmacotherapy of haemophilia A.The future of hemostasis management.Sequential therapy with activated prothrombin complex concentrates and recombinant activated factor VII to treat unresponsive bleeding in patients with hemophilia and inhibitors: a single center experience.ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective.Recombinant activated factor VII in clinical practice: a 2014 update.Cardiac tamponade in a patient with moderate hemophilia A and factor VIII Inhibitors.Modeling costs and outcomes associated with a treatment algorithm for problem bleeding episodes in patients with severe hemophilia a and high-titer inhibitors.Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment.Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.A systematic approach to controlling problem bleeds in patients with severe congenital haemophilia A and high-titre inhibitors.How I treat inhibitors in haemophilia.
P2860
Q24187069-762AF6E5-B06E-4EE7-829C-99C3491264B5Q24236388-0D994877-59B6-4614-8378-0372A28225B8Q24247217-A2A96CC2-22F7-4188-9DB7-7849350BD0AEQ28081532-3A9034E6-8CCB-4A7C-9741-C7F35D1630F7Q30481770-859699FC-7D14-4F15-B416-7C265F63E909Q30493686-FE1D8AAD-1E1E-4B60-8DB5-5FA7D618EB78Q34416394-D0A99EE7-DCFF-483E-A700-6969B2952CBAQ34999749-2F07CEA7-BB21-4BFA-A640-1C21A28157C3Q35265369-F453080B-B4CA-4D0F-9189-86CB976E1C2FQ35895871-8BDC9C34-7138-4487-A95F-6AB8DB97D32DQ36283835-B99257C9-5F8F-49C1-9FA8-927606A69A6AQ36283841-987245AE-7EC5-4128-8A9A-0AC1714139FFQ36283844-8E5427C3-7D33-460B-89C9-8846C2A78D1BQ36291064-C21C5F52-78EF-407D-9AD5-8330BFCA8C62Q36349585-50C7D3E1-2976-445C-83C2-FCB1089ED228Q36473080-32820691-BC08-444C-897F-B8C2E87E14EEQ36480548-15684ACD-A3E8-44DA-AE00-E91EF67B8400Q36570888-45580267-92D5-4E45-8CC9-137BE26EAC24Q36646985-FEF2FC61-8C3E-442F-B822-E8796C4D3364Q36661839-0F07C47F-7DB6-411A-B457-E015804F8BCCQ36810282-6CE280B1-5D21-411C-B5F5-DE4DE26D6936Q36828144-C4FEF2A0-8F08-478D-8420-6E634491F1E4Q37084942-FB256897-B8CE-4DAF-A0A3-D4C12115791CQ37169669-A76DEB19-6AA2-4A44-A5E0-74C73C540447Q37244126-C4B57A2A-D133-49AC-9DF8-3D0CD3AB85DCQ37578173-866D86EE-8A58-422C-8C9C-DAABEBE4BB6AQ37842692-F0496B54-1230-4498-8959-6ACF01C2C662Q37891089-1373D8A9-80D2-42D1-BA4C-9800FA6F2EE6Q38056457-78E6F316-0B26-45A4-97A1-B83552EF81BCQ38182105-57B139B0-2F32-4275-89B9-E8A3DAAB7AB7Q38224296-2C37CC1F-B474-44D5-BD76-9C89A8B32EFCQ38228494-81EAE9B0-EBF1-4288-81DF-FA56C98B1E97Q42555795-BEB73CB7-5DDA-4866-8C8E-A1FE17B74D0EQ42776949-8FF4CED2-746B-4C7F-BC5C-E2F2F9B7259AQ45260428-9D87693F-9609-46A8-8A48-2495E39F957FQ45864880-5FA4D274-19CE-49DA-A58A-C56C9FADBDBDQ45868043-E0183A28-F410-4397-B559-408B76BAFFC1Q45879927-BBE00DE9-7850-4E3A-8344-8796DC63E623
P2860
Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
@ast
Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
@en
type
label
Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
@ast
Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
@en
prefLabel
Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
@ast
Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
@en
P2093
P2860
P1433
P1476
Control of bleeding in patients with haemophilia A with inhibitors: a systematic review.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2516.2003.00782.X
P577
2003-07-01T00:00:00Z